Nvidia faces challenges with Chinese probes and stock dips, while advancing AI in healthcare.

1. Chinese Competition Probe

China has launched an investigation into Nvidia’s 2019 acquisition of Mellanox Technologies, potentially impacting Nvidia’s operations in a key market amid U.S.-China tech tensions.

2. Stock Market Dip

Nvidia’s stock dropped over 13%, losing nearly $480 billion in value, following the emergence of DeepSeek, a Chinese startup with a cost-efficient AI model.

3. Healthcare Innovations

Nvidia announced new partnerships leveraging AI for breakthroughs in drug discovery and genomic research, showcasing its commitment to transformative applications.